Centre for Nanotechnology in Medicine
The multi-disciplinary teams in the Centre for Nanotechnology in Medicine work to create advanced therapeutic and diagnostic tools by exploiting nanoscale materials. These nanomaterials could be both naturally occurring or synthetic but are all engineered to allow more effective detection or treatment of disease.
The Centre for Nanotechnology in Medicine specialises in using nanoscale technologies in different application areas, such as omics (proteomics, genomics, lipidomics), inflammation, cell biology, neuro, therapeutics, and materials, to create new ways of diagnosing and treating disease. By understanding the structures of our cells and how nanomaterials (both biological and synthetic) interact with them, we can learn how to exploit them and develop more targeted treatments for conditions such as cancer and neurodegenerative disease.
A key component of the Centre’s research is developing preclinical disease models, which allow direct translation to the patient applications. With these capabilities, the Centre and its researchers are involved in numerous projects with health and clinical partners, such as the NHS and Cancer Research UK, to bring these new technologies to the medical frontlines.
Our impact
The Nanomedicine Lab’s research is already having an impact on patient outcomes, see how in these case studies.
Speak to our experts
Professor Kostas Kostarelos Chair of Nanomedicine
Dedicated to the development of nanomaterials, advanced materials and devices for therapeutic and diagnostics applications. Clinical translation of nanotechnology and nanoscience is the main expertise and driver.
Dr Marilena Hadjidemetriou Lecturer in NanoOmics
Aims to generate fundamental knowledge about the interaction of nanomaterials with blood components, with the ultimate goal to unveil novel biomarker panels for disease detection and monitoring, and untangle underlying biological processes and molecular pathways.
Dr Cyrill Bussy Senior Lecturer in NanoInflammation
Studies how nanomaterials may trigger inflammation or be used to modulate inflammation and control disease.
Dr Sandra Vranic Lecturer in NanoCell Biology
Explores interactions of nanomaterials with cells focusing on deciphering their interactions with plasma membrane, cellular uptake pathways and intracellular trafficking/subcellular localisation.
Dr Rob Wykes Senior Lecturer in NanoNeuro
Aims to utilise implanted graphene-based technologies (transistor arrays and stimulating electrodes) to gain a better understanding of neurological disease pathology and to offer novel therapeutic options.
Dr Tom Kisby Senior Scientist in NanoTherapeutics
Aims to exploit the properties of nanoparticles and their interactions with cells and tissues for the development of safe and effective medicines, using clinically-relevant disease models.
